Antonio Medina de Almeida
AuthID: R-000-T91
21
TITLE: Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial Full Text
AUTHORS: Garcia Manero, G; Almeida, A; Fenaux, P; Gattermann, N; Giagounidis, A; Goldberg, SL; Ozawa, K; Weaver, J; Santini, V;
PUBLISHED: 2019, SOURCE: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, VOLUME: 19, ISSUE: 4
AUTHORS: Garcia Manero, G; Almeida, A; Fenaux, P; Gattermann, N; Giagounidis, A; Goldberg, SL; Ozawa, K; Weaver, J; Santini, V;
PUBLISHED: 2019, SOURCE: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, VOLUME: 19, ISSUE: 4
INDEXED IN: 
Scopus 
WOS
Scopus WOS IN MY: 
ORCID
ORCID22
TITLE: Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients in Clinical Practice Full Text
AUTHORS: Antonio Almeida; Francesca Pierdomenico; Blanca Polo Guerrero; Filipa Saraiva; Ana Montalvao; Jorge Coutinho; Mario Mariz; Teresa Melo; Maria Joao Santos; Alexandra Pereira; Nuno Cerveira;
PUBLISHED: 2019, SOURCE: ACTA MEDICA PORTUGUESA, VOLUME: 32, ISSUE: 7-8
AUTHORS: Antonio Almeida; Francesca Pierdomenico; Blanca Polo Guerrero; Filipa Saraiva; Ana Montalvao; Jorge Coutinho; Mario Mariz; Teresa Melo; Maria Joao Santos; Alexandra Pereira; Nuno Cerveira;
PUBLISHED: 2019, SOURCE: ACTA MEDICA PORTUGUESA, VOLUME: 32, ISSUE: 7-8
INDEXED IN: WOS
WOS23
TITLE: The European Hematology Exam: The Next Step toward the Harmonization of Hematology Training in Europe
AUTHORS: Navarro, JT; Birgegard, G; Strivens, J; Hollegien, WWG; van Hattem, N; Saris, MT; Wondergem, MJ; Toh, CH; Almeida, AM;
PUBLISHED: 2019, SOURCE: HEMASPHERE, VOLUME: 3, ISSUE: 5
AUTHORS: Navarro, JT; Birgegard, G; Strivens, J; Hollegien, WWG; van Hattem, N; Saris, MT; Wondergem, MJ; Toh, CH; Almeida, AM;
PUBLISHED: 2019, SOURCE: HEMASPHERE, VOLUME: 3, ISSUE: 5
24
TITLE: Treatment of Anemia in Transfusion-Dependent and Non-Transfusion-Dependent Lower-Risk MDS: Current and Emerging Strategies
AUTHORS: Germing, U; Oliva, EN; Hiwase, D; Almeida, A;
PUBLISHED: 2019, SOURCE: HEMASPHERE, VOLUME: 3, ISSUE: 6
AUTHORS: Germing, U; Oliva, EN; Hiwase, D; Almeida, A;
PUBLISHED: 2019, SOURCE: HEMASPHERE, VOLUME: 3, ISSUE: 6
25
TITLE: I-Care for MDS: Development of Guidelines-Based Indicators for Appropriate Care in Adult Patients with Myelodysplastic Syndromes
AUTHORS: Kristina Stojkov; Tobias Silzle; Georg Stussi; David Schwappach; Juerg Bernhard; David Bowen; Jaroslav Cermak; Avinash G Dinmohamed; Corien Eeltink; Sabrina Eggmann; Pierre Fenaux; Ulrich Germing; Manuel Haschke; Eva Hellstrom Lindberg; Monika Heger; Arjan A Van de Loosdrecht; Jakob R Passweg; Michael Pfeilstocker; Uwe Platzbecker; Luca Malcovati; ...More
PUBLISHED: 2019, SOURCE: Blood, VOLUME: 134, ISSUE: Supplement_1
AUTHORS: Kristina Stojkov; Tobias Silzle; Georg Stussi; David Schwappach; Juerg Bernhard; David Bowen; Jaroslav Cermak; Avinash G Dinmohamed; Corien Eeltink; Sabrina Eggmann; Pierre Fenaux; Ulrich Germing; Manuel Haschke; Eva Hellstrom Lindberg; Monika Heger; Arjan A Van de Loosdrecht; Jakob R Passweg; Michael Pfeilstocker; Uwe Platzbecker; Luca Malcovati; ...More
PUBLISHED: 2019, SOURCE: Blood, VOLUME: 134, ISSUE: Supplement_1
26
TITLE: Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study Group
AUTHORS: Lisa Pleyer; Michael Leisch; Alexandra Kourakli; Eric Padron; Jaroslaw P Maciejewski; Blanca Xicoy; Jennifer Kaivers; Johanna Ungerstedt; Sonja Heibl; Peristera Patiou; Anthony M Hunter; Elvira Mora; Klaus Geissler; Maria Dimou; María-José Jimenez; David Kiesl; Nora-Athina Viniou; Bhumika J Patel; Montserrat Arnan Sangerman; Peter Valent; ...More
PUBLISHED: 2019, SOURCE: Blood, VOLUME: 134, ISSUE: Supplement_1
AUTHORS: Lisa Pleyer; Michael Leisch; Alexandra Kourakli; Eric Padron; Jaroslaw P Maciejewski; Blanca Xicoy; Jennifer Kaivers; Johanna Ungerstedt; Sonja Heibl; Peristera Patiou; Anthony M Hunter; Elvira Mora; Klaus Geissler; Maria Dimou; María-José Jimenez; David Kiesl; Nora-Athina Viniou; Bhumika J Patel; Montserrat Arnan Sangerman; Peter Valent; ...More
PUBLISHED: 2019, SOURCE: Blood, VOLUME: 134, ISSUE: Supplement_1
27
TITLE: Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS Full Text
AUTHORS: de Swart, L; Smith, A; Haase, D; Fenaux, P; Symeonidis, A; Cermak, J; Sanz, G; Stauder, R; Mittelman, M; Hellstrom Lindberg, E; Malcovati, L; Langemeijer, S; Skov Holm, M; Madry, K; Germing, U; Almeida, AM; Tatic, A; Savic, A; Simec, NG; van Marrewijk, C; ...More
PUBLISHED: 2018, SOURCE: LEUKEMIA RESEARCH, VOLUME: 67
AUTHORS: de Swart, L; Smith, A; Haase, D; Fenaux, P; Symeonidis, A; Cermak, J; Sanz, G; Stauder, R; Mittelman, M; Hellstrom Lindberg, E; Malcovati, L; Langemeijer, S; Skov Holm, M; Madry, K; Germing, U; Almeida, AM; Tatic, A; Savic, A; Simec, NG; van Marrewijk, C; ...More
PUBLISHED: 2018, SOURCE: LEUKEMIA RESEARCH, VOLUME: 67
28
TITLE: The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 Study Full Text
AUTHORS: Santini, V; Almeida, A; Giagounidis, A; Platzbecker, U; Buckstein, R; Beach, CL; Guo, SE; Altincatal, A; Wu, CQ; Fenaux, P;
PUBLISHED: 2018, SOURCE: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, VOLUME: 18, ISSUE: 2
AUTHORS: Santini, V; Almeida, A; Giagounidis, A; Platzbecker, U; Buckstein, R; Beach, CL; Guo, SE; Altincatal, A; Wu, CQ; Fenaux, P;
PUBLISHED: 2018, SOURCE: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, VOLUME: 18, ISSUE: 2
29
TITLE: Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial Full Text
AUTHORS: Saussele, S; Richter, J; Guilhot, J; Gruber, FX; Hjorth Hansen, H; Almeida, A; Janssen, JJWM; Mayer, J; Koskenvesa, P; Panayiotidis, P; Olsson Strömberg, U; Martinez Lopez, J; Rousselot, P; Vestergaard, H; Ehrencrona, H; Kairisto, V; Machová Poláková, K; Müller, MC; Mustjoki, S; Berger, MG; ...More
PUBLISHED: 2018, SOURCE: The Lancet Oncology, VOLUME: 19, ISSUE: 6
AUTHORS: Saussele, S; Richter, J; Guilhot, J; Gruber, FX; Hjorth Hansen, H; Almeida, A; Janssen, JJWM; Mayer, J; Koskenvesa, P; Panayiotidis, P; Olsson Strömberg, U; Martinez Lopez, J; Rousselot, P; Vestergaard, H; Ehrencrona, H; Kairisto, V; Machová Poláková, K; Müller, MC; Mustjoki, S; Berger, MG; ...More
PUBLISHED: 2018, SOURCE: The Lancet Oncology, VOLUME: 19, ISSUE: 6
30
TITLE: Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial Full Text
AUTHORS: Almeida, A; Fenaux, P; Garcia Manero, G; Goldberg, SL; Gropper, S; Jonasova, A; Vey, N; Castaneda, C; Zhong, JH; Beach, CL; Santini, V;
PUBLISHED: 2018, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 59, ISSUE: 9
AUTHORS: Almeida, A; Fenaux, P; Garcia Manero, G; Goldberg, SL; Gropper, S; Jonasova, A; Vey, N; Castaneda, C; Zhong, JH; Beach, CL; Santini, V;
PUBLISHED: 2018, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 59, ISSUE: 9
